Category: Breaking

Pfizer/BioNTech Covid-19 Booster ‘Neutralizes’ Omicron Variant, Companies Say

The vaccine has “significantly reduced” protection against omicron after only two shots, early data suggests.

Australian State Detects Omicron Variant Offshoot That Might Be Harder To Track

This new lineage is still being classified as omicron but it cannot be detected using the typical screening method for that variant.

Early Reports From U.K., Norway, South Africa Suggest Omicron Variant Is More Transmissible But Causes Milder Covid-19

Experts warn it is too early to draw firm conclusions on the matter.

Here’s How Covid-19 Vaccine Makers Plan To Tackle Omicron

Some of the world’s biggest producers of Covid-19 vaccines are divided over whether the shots protect against omicron, while new, variant-specific vaccines are already being developed.

Dow Jumps 700 Points Despite Growing Number Of Omicron Cases

The market rebounded strongly after last week’s omicron-induced sell-off.

Viagra Use May Reduce Risk Of Getting Alzheimer’s By Nearly 70%, Study Suggests

Researchers say the drug, used to treat erectile dysfunction and high blood pressure, should be studied as a possible Alzheimer’s treatment.

Covid Outbreak From Norwegian Cruise Grows To 17 Cases—With At Least 1 Omicron

The probable omicron case was among a crew member who “was in isolation for the entirety of the cruise,” according to Norwegian.

Italy’s Unvaccinated Face More Restrictions Ahead Of Holidays As Covid-19 Cases Rise

Italy, which has one of the highest vaccination rates in the world, will require proof of vaccination or recovery to enter many public spaces and a negative test to use public transport.

FDA Authorizes Eli Lilly’s Covid Antibody Therapy For Emergency Use In Young Children

This is the FDA’s first emergency use authorization of a Covid-19 monoclonal antibody treatment in kids as young as newborns.

Is The Era Of Stay-At-Home Stocks Over? Here’s Why Zoom, Peloton And Others Have Slumped In 2021

Some of the pandemic’s hottest stay-at-home stocks have undergone brutal sell-offs this year.